Background: Over a 36-month study period, 10 nonconsecutive neuromuscular pediatric patients (6 infants, mean age 10.16 months, and 4 children, mean age 9.3 years) presenting with acute respiratory failure (ARF) were treated by noninvasive positive pressure ventilation (NPPV). All patients required immediate respiratory support and fulfilled our intubation criteria. Objective: The aim of the study was to verify if early NPPV was able to avoid endotracheal intubation and to improve both oxygenation and ventilation within 24 h from admission in this clinical setting. Patients andMethods: A prospective pilot study was carried out on neuromuscular patients admitted to the pediatric intensive care unit (PICU) of the Catholic University of Rome because of ARF and managed exclusively with NPPV for at least 24 h following admission. All patients were treated using a flow-triggered mechanical ventilator through a face mask or using the new helmet interface. Results: Eight patients were successfully ventilated during the observation period and 2 early failures occurred. Among children undergoing face mask NPPV, the PaO2/FiO2 ratio increased from a median value of 75 (range 48–149) to 240 (range 133–385; p < 0.001) and 328 (range 180–371; p < 0.001) at selected time points (3 and 12 h after NPPV introduction, respectively); the alveolar-to-arterial oxygenation difference showed a similar trend, i.e. decreasing from a median value of 589 (range 213–659) to 128 (range 62–527; p < 0.01) and 69 (range 45–207; p < 0.001), respectively. Hypercarbic ARF resolved within 6 h from admission even in the most severe cases. Conclusions: NPPV was a safe and effective first-line therapeutic approach in hypoxemic ARF children/infants with neuromuscular disease. It seems of importance to identify children with neuromuscular disorders who may be able to achieve residual ventilator-free breathing and to perform an NPPV trial avoiding tracheal intubation. Life-threatening respiratory distress and very young age should not preclude NPPV application in the PICU setting. The new helmet interface represents a promising tool for noninvasive ventilation in older children.

1.
Bach JR: Prevention of morbidity and mortality with the use of physical medicine aids; in Bach JR (ed): Pulmonary Rehabilitation: The Obstructive and Paralytic-Restrictive Syndromes. Philadelphia, Hanley & Belfus 1996, pp 303–329.
2.
Levine SA, Niederman MS: The impact of tracheal intubation on host defence and risk for nosocomial pneumonia. Clin Chest Med 1991;12:523–543.
3.
Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR: Risk factors for pneumonia in patients receiving mechanical ventilation. Am Rev Respir Dis 1986;133:792–796.
4.
De Paillette L, Aicardi J, Goutières F: Ullrich’s congenital atonic sclerotic muscular dystrophy. J Neurol 1989;236:108–110.
5.
Wallgren-Pettersson C: Congenital nemaline myopathy. J Neurol Sci 1989;89:1–14.
6.
Ellis ER, Grunstein RR, Chan S, Bye PT, Sullivan CE: Noninvasive ventilatory support during sleep improves respiratory failure in kyphoscoliosis. Chest 1988;94:811–815.
7.
Padman R, Lawless S, von Nessen S: Use of BiPAP by nasal mask in the treatment of respiratory insufficiency in pediatric patients: preliminary investigation. Pediatr Pulmonol 1994;17:119–123.
8.
Pope JF, Birnkrant DJ: Noninvasive ventilation to facilitate extubation in a pediatric intensive care unit. J Intensive Care Med 2000;15:99–103.
9.
Teague WG: Pediatric application of noninvasive ventilation. Respir Care 1997;42:414–423.
10.
Akingbola OA, Hopkins RL: Pediatric noninvasive positive pressure ventilation. Pediatr Crit Care Med 2001;2:164–169.
11.
Vianello A, Bevilacqua M, Salvador V, Cardaioli C, Vincenti E: Long-term nasal intermittent positive pressure ventilation in advanced Duchenne’s muscular dystrophy. Chest 1994;105:445–448.
12.
Bach JR, Ishikawa Y, Kim H: Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest 1997;112:1024–1028.
13.
Piper AJ, Parker S, Torzillo PJ, Sullivan CE, Bye PT: Nocturnal nasal IPPV stabilizes patients with cystic fibrosis and hypercapnic respiratory failure. Chest 1992;102:846–850.
14.
Hodson ME, Madden BP, Steven MH, Tsang VT, Yacoub MH: Non-invasive mechanical ventilation for cystic fibrosis patients – a potential bridge to transplantation. Eur Respir J 1991;4:524–527.
15.
Gozal DC, Kaufman S: Paediatric nocturnal ventilatory support in patients with cystic fibrosis: comparison with supplemental oxygen. Eur Respir J 1997;10:1999–2003.
16.
Niranjan V, Bach JR: Noninvasive management of pediatric neuromuscular ventilatory failure. Crit Care Med 1998;26:2061–2065.
17.
Fortenberry JD, Del Toro J, Jefferson LS, Evey L, Haase D: Management of pediatric acute hypoxemic respiratory insufficiency with bilevel positive pressure nasal mask ventilation. Chest 1995;108:1059–1064.
18.
Akingbola OA, Servant GM, Custer JR, et al: Noninvasive bilevel positive pressure ventilation: management of two pediatric patients. Respir Care 1993;38:1092–1098.
19.
Dunaway J, McIntosch JC, Schoumacher RA: Nasal mask ventilation of two young patients with restrictive lung disease associated with kyphoscoliosis. Respir Care 1991;36:1315.
20.
Ellis ER, McCauley VB, Mellis C, Sullivan CE: Treatment of alveolar hypoventilation in a six-year old girl with intermittent positive pressure ventilation through a nose mask. Am Rev Respir Dis 1987;136:188–191.
21.
Padman R, Nadkarni VM: Noninvasive nasal mask positive pressure ventilation in a pediatric patient with acute hypoxic respiratory failure. Ped Emerg Care 1996;12:44–47.
22.
Marino P, Rosa G, Conti G, Cogliati AA: Treatment of acute respiratory failure by prolonged non-invasive ventilation in a child. Can J Anaesth 1997;44:727–731.
23.
Hotchkiss JR, Marini JJ: Noninvasive ventilation: an emerging supportive technique for the emergency department. Ann Emerg Med 1998;32:470–479.
24.
Vianello A, Bevilacqua M, Arcaro G, Gallan F, Serra E: Non-invasive ventilatory approach to treatment of acute respiratory failure in neuromuscular disorders. A comparison with endotracheal intubation. Intensive Care Med 2000;26:384–390.
25.
Bott J, Carroll MP, Conway JH, Keilty SE, Ward EM, Brown AM, Paul EA, Elliott MW, Godfrey RC, Wedzicha JA, et al: Randomized controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airway disease. Lancet 1993;341:1555–1557.
26.
Kramer N, Meyer TJ, Meharg J, Cece RD, Hill NS: Randomized prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 1995;27:189–192.
27.
Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A, Simonneau G, Benito S, Gasparetto A, Lemaire F: Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995;333:817–822.
28.
Valipour A, Cozzarini W, Burghuber OC: Non-invasive pressure support ventilation in patients with respiratory failure due to severe acute cardiogenic pulmonary edema. Respiration 2004;71:144–151.
29.
Park M, Sangean MC, Volpe Mde S, Feltrim MI, Nozawa E, Leite PF, Passos Amato MB, Lorenzi-Filho G: Randomized, prospective trial of oxygen, continuous positive airway pressure, and bilevel positive airway pressure by face mask in acute cardiogenic pulmonary edema. Crit Care Med 2004;32:2407–2415.
30.
Teague WG: Noninvasive ventilation in the pediatric intensive care unit for children with acute respiratory failure. Pediatr Pulmonol 2003;35:418–426.
31.
Shah PS, Ohlsson A, Shah JP: Continuous negative extrathoracic pressure or continuous positive airway pressure for acute hypoxemic respiratory failure in children. Cochrane Database Syst Rev, 2003, CD003699.
32.
Cheifetz IM: Invasive and noninvasive pediatric mechanical ventilation. Respir Care 2003;48:442–453.
33.
Norregaard O: Noninvasive ventilation in children. Eur Respir J 2002;20:1332–1342.
34.
Carvalho WB, Fonseca MC: Noninvasive ventilation in pediatrics: we still do not have a consistent base. Pediatr Crit Care Med 2004;5:408–409.
35.
Barthlen GM: Nocturnal respiratory failure as an indication of noninvasive ventilation in the patient with neuromuscular disease. Respiration 1997;64(suppl 1):35–38.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.